查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1463112

沙眼治療市場、佔有率、規模、趨勢、行業分析報告：依給藥途徑、依藥物類別、依地區、依細分市場、預測，2024-2032 年

Trachoma Treatment Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral and Topical); By Drug Class; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球沙眼治療市場預計將達到9.2443億美元。 該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

沙眼盛行率的快速增加以及私人和公共醫療保健組織的普及以提高公眾對沙眼及其治療選擇的認識是推動市場成長的突出因素。 例如，2024年1月，生活在活動性沙眼高發地區的人口估計到2023年約為1.16億，超過150萬人需要接受倒睫手術。

此外，為了遏制可預防性失明的蔓延，世界各地正在增加有利的監管政策和激勵計劃，以促進新沙眼治療方法的開發，進一步推動市場成長。 例如，2024年2月，聯邦政府宣佈啟動一項新計劃，消除沙眼、瘧疾、絲蟲病、盤尾絲蟲病和瘧疾等疾病。

此外，由於沙眼在中東和非洲和亞太地區的欠發達經濟體和發展中國家最為普遍，因此越來越需要顯著改善醫療基礎設施，全球和醫療保健公司正在幫助擴大其在新興市場的業務。 隨著公司和政府增加對醫療基礎設施的投資並使更多患者更容易獲得醫療服務，對有效沙眼治療方案的需求將呈指數級增長。 例如，根據國際貿易署的數據，2024年1月，馬來西亞政府持續加強醫療保健領域，將國家醫療保健預算從2022年的710萬美元增加到790萬美元。

能夠遠端診斷和治療沙眼的數位健康技術和遠距醫療正在世界各地興起，為提供沙眼治療解決方案的公司創造了利潤豐厚的機會。 此外，專注於開發沙眼預防產品的公司，包括衛生和環境衛生解決方案以及比傳統解決方案更容易管理且更實惠的新藥物，可能在市場上具有很高的競爭優勢。

沙眼治療市場報告亮點

口服藥物由於具有全身性覆蓋、降低污染風險和東方給藥等特點，佔了顯著的佔有率。

大環內酯類藥物以其價格實惠、抗藥性細菌少、易取得、療程短等特徵佔了較大的市場佔有率。

北美憑藉其成熟的醫療基礎設施和不斷增加的開發新解決方案的研發活動而在全球市場佔主導地位。

主要市場參與者包括艾爾建公司(Allergan Inc.)、禮來公司(Eli Lilly and Company)、拜耳公司(Bayer AG)、Bausch Health Companies、Cipla、諾華公司(Novartis AG)、Arbor Pharmaceuticals 和艾伯維(AbbVie)。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第四章全球沙眼治療市場洞察

  • 沙眼治療市場 - 產業概況
  • 沙眼治療市場動態
    • 推動者和機會
      • 沙眼流行和疾病預防意識的提高推動了成長
      • 醫療保健成本的改善和治療方法的進步推動市場成長
    • 抑制因素和課題
      • 治療費用高且缺乏認識
  • 杵分析
  • 沙眼治療產業趨勢
  • 價值鏈分析
  • 新冠肺炎 (COVID-19) 影響分析

第 5 章依管理途徑劃分的全球市場

  • 主要發現
  • 簡介
  • 口頭
  • 外部使用

第 6 章依藥物類別劃分的世界市場

  • 主要發現
  • 簡介
  • 大環內酯
  • 四環素
  • 眼科抗感染藥
  • 磺醯胺

第 7 章依地區劃分的世界市場

  • 主要發現
  • 簡介
    • 2019-2032 年沙眼治療市場評估（依地區）
  • 沙眼治療市場 - 北美
    • 北美：沙眼治療市場，依藥物類別，2019-2032 年
    • 北美：沙眼治療市場，依給藥途徑劃分，2019-2032 年
    • 沙眼治療市場 - 美國
    • 沙眼治療市場 - 加拿大
  • 沙眼治療市場 - 歐洲
    • 歐洲：沙眼治療市場，依藥物類別，2019-2032 年
    • 歐洲：沙眼治療市場（依給藥途徑），2019-2032 年
    • 沙眼治療市場 - 英國
    • 沙眼治療市場 - 法國
    • 沙眼治療市場 - 德國
    • 沙眼治療市場 - 義大利
    • 沙眼治療市場 - 西班牙
    • 沙眼治療市場 - 荷蘭
    • 沙眼治療市場 - 俄羅斯
  • 沙眼治療市場 - 亞太地區
    • 亞太地區：沙眼治療市場，依藥物類別，2019-2032 年
    • 亞太地區：沙眼治療市場，依給藥途徑劃分，2019-2032 年
    • 沙眼治療市場 - 中國
    • 沙眼治療市場 - 印度
    • 沙眼治療市場 - 馬來西亞
    • 沙眼治療市場 - 日本
    • 沙眼治療市場 - 印尼
    • 沙眼治療市場 - 韓國
  • 沙眼治療市場 - 中東和非洲
    • 中東與非洲：沙眼治療市場（依藥物類別），2019-2032 年
    • 中東與非洲：沙眼治療市場，依給藥途徑劃分，2019-2032 年
    • 沙眼治療市場 - 沙烏地阿拉伯
    • 沙眼治療市場 - 阿聯酋
    • 沙眼治療市場 - 以色列
    • 沙眼治療市場 - 南非
  • 沙眼治療市場 - 拉丁美洲
    • 拉丁美洲：沙眼治療市場，依藥物類別，2019-2032 年
    • 拉丁美洲：沙眼治療市場，依給藥途徑劃分，2019-2032 年
    • 沙眼治療市場 - 墨西哥
    • 沙眼治療市場 - 巴西
    • 沙眼治療市場 - 阿根廷

第八章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 合作/協作/合約/出版物

第九章公司簡介

  • Abbott Laboratories
  • AbbVie Inc.
  • Allergan Inc
  • Arbor Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • Bayer AG.
  • Cipla Inc
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
Product Code: PM4785

The global trachoma treatment market size is expected to reach USD 924.43 million by 2032, according to a new study by Polaris Market Research. The report "Trachoma Treatment Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral and Topical); By Drug Class; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rapid increase in the prevalence of trachoma and its proliferation among private and public healthcare organizations to raise awareness about trachoma and its treatment options among the general public are prominent factors driving the market growth. For instance, in January 2024, the number of people living in districts with a high prevalence of active trachoma was estimated at around 116 million in 2023, and over 1.5 million people required surgery for trichiasis.

In addition, a growing number of favorable regulatory policies and incentive programs promoting the development of new trachoma treatments to control the spread of preventable blindness worldwide, further boosting market growth. For instance, in February 2024, The Federal government announced the launch of its new program to eliminate diseases, including trachoma, malaria, filariasis, onchocerciasis, and goehelminthiasis

Furthermore, as trachoma is most prevalent is under-developed or developing economies of MEA and APAC region, thereby the need for significant improvements in healthcare infrastructure is growing and encouraging global healthcare companies to expand their market presence in these emerging and untapped markets. With companies and governments increasingly investing in healthcare infrastructure development and making healthcare services easily accessible to a larger patient population, the demand for effective trachoma treatment options will boost drastically. For instance, according to the International Trade Administration, in January 2024, the Malaysian government continued to strengthen its healthcare sector, increasing the national budget for healthcare to USD 7.9 million compared to USD 7.1 million in 2022.

The emergence of digital health technologies and telemedicine across the globe, which enables the remote diagnosis and treatment of trachoma, is presenting a lucrative opportunity for companies providing trachoma treatment solutions. Also, companies focusing on the development of products for trachoma prevention including hygiene and sanitation solutions and new drugs that are easy to administer and affordable as compared to conventional solutions, are likely to gain a competitive edge in the market.

Trachoma Treatment Market Report Highlights

Oral segment accounted for a noteworthy share, which is attributed to its characteristics, including systemic coverage, reduced contamination risk, and east administration

The macrolides segment held a significant share due to its affordability, reduced resistance, easy availability, and shorter treatment time

North America dominated the global market on account of well-established healthcare infrastructure and rising R&D activities for the development of new solutions

The key market players include Allergan Inc., Eli Lilly and Company, Bayer AG, Bausch Health Companies, Cipla, Novartis AG, Arbor Pharmaceuticals, and AbbVie

Polaris Market Research has segmented the trachoma treatment market report based on route of administration, drug class, and region:

Trachoma Treatment, Route of Administration Outlook (Revenue - USD Million, 2019 - 2032)

  • Oral
  • Topical

Trachoma Treatment, Drug Class Outlook (Revenue - USD Million, 2019 - 2032)

  • Macrolides
  • Tetracycline
  • Ophthalmic Anti-Infective
  • Sulfonamides

Trachoma Treatment, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Trachoma Treatment Market Insights

  • 4.1. Trachoma Treatment Market - Industry Snapshot
  • 4.2. Trachoma Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of trachoma and awareness about disease prevention to drive growth
      • 4.2.1.2. Improvements in healthcare expenditure and advancements in treatments to boost market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost associated with treatment and lack of awareness
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Trachoma Treatment Industry trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Trachoma Treatment Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Trachoma Treatment, by Route of Administration, 2019-2032 (USD Million)
  • 5.3. Oral
    • 5.3.1. Global Trachoma Treatment Market, by Oral, by Region, 2019-2032 (USD Million)
  • 5.4. Topical
    • 5.4.1. Global Trachoma Treatment Market, by Topical, by Region, 2019-2032 (USD Million)

6. Global Trachoma Treatment Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • 6.3. Macrolides
    • 6.3.1. Global Trachoma Treatment Market, by Macrolides, by Region, 2019-2032 (USD Million)
  • 6.4. Tetracycline
    • 6.4.1. Global Trachoma Treatment Market, by Tetracycline, by Region, 2019-2032 (USD Million)
  • 6.5. Ophthalmic Anti-infective
    • 6.5.1. Global Trachoma Treatment Market, by Ophthalmic Anti-infective, by Region, 2019-2032 (USD Million)
  • 6.6. Sulfonamides
    • 6.6.1. Global Trachoma Treatment Market, by Sulfonamides, by Region, 2019-2032 (USD Million)

7. Global Trachoma Treatment Market, by Geography

  • 7.1. Key findings
  • 7.2. Introduction
    • 7.2.1. Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • 7.3. Trachoma Treatment Market - North America
    • 7.3.1. North America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.3.2. North America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.3.3. Trachoma Treatment Market - U.S.
      • 7.3.3.1. U.S.: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.3.3.2. U.S.: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.3.4. Trachoma Treatment Market - Canada
      • 7.3.4.1. Canada: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.3.4.2. Canada: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.4. Trachoma Treatment Market - Europe
    • 7.4.1. Europe: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.4.2. Europe: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.3. Trachoma Treatment Market - UK
      • 7.4.3.1. UK: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.3.2. UK: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.4. Trachoma Treatment Market - France
      • 7.4.4.1. France: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.4.2. France: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.5. Trachoma Treatment Market - Germany
      • 7.4.5.1. Germany: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.5.2. Germany: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.6. Trachoma Treatment Market - Italy
      • 7.4.6.1. Italy: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.6.2. Italy: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.7. Trachoma Treatment Market - Spain
      • 7.4.7.1. Spain: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.7.2. Spain: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.8. Trachoma Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.8.2. Netherlands: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.4.9. Trachoma Treatment Market - Russia
      • 7.4.9.1. Russia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.4.9.2. Russia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.5. Trachoma Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.5.2. Asia Pacific: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.3. Trachoma Treatment Market - China
      • 7.5.3.1. China: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.3.2. China: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.4. Trachoma Treatment Market - India
      • 7.5.4.1. India: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.4.2. India: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.5. Trachoma Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.5.2. Malaysia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.6. Trachoma Treatment Market - Japan
      • 7.5.6.1. Japan: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.6.2. Japan: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.7. Trachoma Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.7.2. Indonesia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.5.8. Trachoma Treatment Market - South Korea
      • 7.5.8.1. South Korea: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.5.8.2. South Korea: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.6. Trachoma Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.6.2. Middle East & Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.3. Trachoma Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.3.2. Saudi Arabia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.4. Trachoma Treatment Market - UAE
      • 7.6.4.1. UAE: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.4.2. UAE: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.5. Trachoma Treatment Market - Israel
      • 7.6.5.1. Israel: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.5.2. Israel: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.6.6. Trachoma Treatment Market - South Africa
      • 7.6.6.1. South Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.6.6.2. South Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • 7.7. Trachoma Treatment Market - Latin America
    • 7.7.1. Latin America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
    • 7.7.2. Latin America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.7.3. Trachoma Treatment Market - Mexico
      • 7.7.3.1. Mexico: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.7.3.2. Mexico: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.7.4. Trachoma Treatment Market - Brazil
      • 7.7.4.1. Brazil: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.7.4.2. Brazil: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
    • 7.7.5. Trachoma Treatment Market - Argentina
      • 7.7.5.1. Argentina: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
      • 7.7.5.2. Argentina: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. AbbVie Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Allergan Inc
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Arbor Pharmaceuticals Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Bausch Health Companies Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Bayer AG.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Cipla Inc
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Eli Lilly and Company
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. F. Hoffmann-La Roche Ltd
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Merck & Co. Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Mylan NV
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Novartis AG
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. Pfizer Inc.
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. Sanofi SA
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development

List of Tables

  • Table 1 Global Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 2 Global Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 3 Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 4 North America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 5 North America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 6 U.S.: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 7 U.S.: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 8 Canada: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 9 Canada: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 10 Europe: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 11 Europe: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 12 UK: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 13 UK: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 14 France: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 15 France: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 16 Germany: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 17 Germany: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 18 Italy: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 19 Italy: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 20 Spain: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 21 Spain: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 22 Netherlands: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 23 Netherlands: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 24 Russia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 25 Russia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 26 Asia Pacific: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 27 Asia Pacific: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 28 China: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 29 China: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 30 India: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 31 India: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 32 Malaysia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 33 Malaysia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 34 Japan: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 35 Japan: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 36 Indonesia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 37 Indonesia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 38 South Korea: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 39 South Korea: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 40 Middle East & Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 41 Middle East & Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 42 Saudi Arabia: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 43 Saudi Arabia: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 44 UAE: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 45 UAE: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 46 Israel: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 47 Israel: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 48 South Africa: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 49 South Africa: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 50 Latin America: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 51 Latin America: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 52 Mexico: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 53 Mexico: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 54 Brazil: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 55 Brazil: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 56 Argentina: Trachoma Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • Table 57 Argentina: Trachoma Treatment Market, by Route of Administration, 2019-2032 (USD Million)

List of Figures

  • Figure 1 Global Trachoma Treatment Market, 2019-2032 (USD Million)
  • Figure 2 Integrated Ecosystem
  • Figure 3 Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4 Market by Geography
  • Figure 5 Porter's Five Forces
  • Figure 6 Market by Drug Class
  • Figure 7 Global Trachoma Treatment Market, by Drug Class, 2022 & 2032 (USD Million)
  • Figure 8 Market by Route of Administration
  • Figure 9 Global Trachoma Treatment Market, by Route of Administration, 2022 & 2032 (USD Million)
  • Figure 10 Trachoma Treatment Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 11 Strategic Analysis - Trachoma Treatment Market